Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Diabetes Health Center

Font Size

Stronger Warning for Some Diabetes Drugs

Makers of Certain Diabetes Drugs Agree to 'Black Box' Warning of Heart Failure Risk
WebMD Health News
Reviewed by Louise Chang, MD

Aug. 14, 2007 -- The FDA today announced that the makers of certain type 2 diabetes drugs have agreed to strengthen the drugs' warnings about the risk of heart failure, a condition in which the heart doesn't adequately pump blood.

The strengthened warning will come in the form of a "black box" warning, the FDA's sternest warning. The upgraded warning emphasizes that the drugs may cause or worsen heart failure in certain patients.

All drugs in the class of diabetes drugs called thiazolidinediones -- which includes the drugs Avandia, Actos, Avandaryl, Avandamet, and Duetact -- will get the black box warning.

Those drugs, which are used in conjunction with diet and exercise to improve blood sugar control in adults with type 2 diabetes, already carried a warning about heart failure risk.

In June, the FDA announced that two drugs in that drug class would get a black box warning.

After reviewing postmarketing adverse event reports, the FDA determined that the entire class of thiazolidinediones needed the black box warning about heart failure risk. The FDA had asked the drugs' makers -- GlaxoSmithKline and Takeda -- to address those concerns.

"This new boxed warning addresses [the] FDA’s concerns that despite the warnings and information already listed in the drug labels, these drugs are still being prescribed to patients without careful monitoring for signs of heart failure," Steven Galson, MD, MPH, director of the FDA's Center for Drug Evaluation and Research, says in an FDA news release.

Black Box Warning

The strengthened warning advises health care professionals to observe patients carefully for the signs and symptoms of heart failure, including excessive, rapid weight gain, shortness of breath, and swelling (edema) after starting drug therapy.

Patients with those symptoms who develop heart failure should receive appropriate management of the heart failure and use of the diabetes drug should be reconsidered, states the FDA.

The warning also states that these drugs shouldn't be used by people with serious or severe heart failure who have marked limits on their activity and who are comfortable only at rest or who are confined to bed or a chair.

The FDA advises people with questions about the risks to contact their health care providers to discuss alternative treatments.

Today on WebMD

Diabetic tools
Symptoms, diagnosis, treatment, and more.
woman flexing muscles
10 strength training exercises.
Blood sugar test
12 practical tips.
Tom Hanks
Stars living with type 1 or type 2.
kenneth fujioka, md
Can Vinegar Treat Diabetes
Middle aged person
Home Healthcare

Prediabetes How to Prevent Type 2 Diabetes
type 2 diabetes
food fitness planner